About this Journal Submit a Manuscript Table of Contents
International Journal of Endocrinology
Volume 2012 (2012), Article ID 972617, 7 pages
http://dx.doi.org/10.1155/2012/972617
Review Article

Diagnosing Growth Hormone Deficiency in Adults

Department of Endocrinology, Beaumont Hospital, RCSI Medical School, Dublin 9, Ireland

Received 6 March 2012; Revised 14 June 2012; Accepted 15 June 2012

Academic Editor: Maria L. Dufau

Copyright © 2012 Nigel Glynn and Amar Agha. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. J. Thomas and J. P. Monson, “Adult GH deficiency throughout lifetime,” European Journal of Endocrinology, vol. 161, supplement 1, pp. S97–S106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. A. S. Al-Shoumer, R. Gray, V. Anyaoku et al., “Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH- deficient adults,” Clinical Endocrinology, vol. 48, no. 6, pp. 795–802, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. H. B. A. Baum, B. M. K. Biller, J. S. Finkelstein et al., “Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency: a randomized, placebo-controlled trial,” Annals of Internal Medicine, vol. 125, no. 11, pp. 883–890, 1996. View at Scopus
  4. G. Götherström, J. Svensson, J. Koranyi et al., “A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 10, pp. 4657–4665, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. W. M. Widdowson and J. Gibney, “The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4413–4417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. K. Y. Ho, “Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia,” European Journal of Endocrinology, vol. 157, no. 6, pp. 695–700, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, and M. L. Vance, “Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 6, pp. 1587–1609, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Gharib, D. M. Cook, P. H. Saenger, et al., “American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children—2003 update,” Endocrine Practice, vol. 9, no. 1, pp. 64–76, 2003.
  9. A. Giustina, A. Barkan, P. Chanson et al., “Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults,” Journal of Endocrinological Investigation, vol. 31, no. 9, pp. 820–838, 2008. View at Scopus
  10. A. Nicolson, A. A. Toogood, A. Rahim, and S. M. Shalet, “The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood,” Clinical Endocrinology, vol. 44, no. 3, pp. 311–316, 1996. View at Scopus
  11. H. K. Gleeson and S. M. Shalet, “The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours,” Endocrine-Related Cancer, vol. 11, no. 4, pp. 589–602, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Hoffman, T. V. Nguyen, A. J. O'Sullivan et al., “Diagnosis of growth hormone deficiency in adults,” The Lancet, vol. 344, no. 8920, pp. 482–483, 1994. View at Scopus
  13. A. T. Reutens, D. M. Hoffman, K. C. Leung, and K. K. Y. Ho, “Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 2, pp. 480–485, 1995. View at Scopus
  14. A. S. Bates, A. J. Evans, P. Jones, and R. N. Clayton, “Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin-like growth factor-I and urinary growth hormone excretion,” Clinical Endocrinology, vol. 42, no. 4, pp. 425–430, 1995. View at Scopus
  15. D. R. Clemmons, “Value of insulin-like growth factor system markers in the assessment of growth hormone status,” Endocrinology and Metabolism Clinics of North America, vol. 36, no. 1, pp. 109–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. Hartman, B. J. Crowe, B. M. K. Biller, K. K. Y. Ho, D. R. Clemmons, and J. J. Chipman, “Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 477–485, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. C. Lee, N. D. Zasler, and J. S. Kreutzer, “Male pituitary-gonadal dysfunction following severe traumatic brain injury,” Brain Injury, vol. 8, no. 6, pp. 571–577, 1994. View at Scopus
  18. J. Svensson, G. Johannsson, and B. Å. Bengtsson, “Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test,” Clinical Endocrinology, vol. 46, no. 5, pp. 579–586, 1997. View at Scopus
  19. G. Aimaretti, G. Corneli, R. Baldelli et al., “Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency,” Clinical Endocrinology, vol. 59, no. 1, pp. 56–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. A. Lissett, P. Jönsson, J. P. Monson, and S. M. Shalet, “Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of onset of GHD,” Clinical Endocrinology, vol. 59, no. 6, pp. 773–778, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. R. Fish, B. Chernow, and J. T. O'Brian, “Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review,” Metabolism, vol. 35, no. 8, pp. 763–780, 1986. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan, “The diagnosis of growth hormone deficiency in children and adults,” Endocrine Reviews, vol. 19, no. 2, pp. 203–223, 1998. View at Scopus
  23. F. M. Finucane, A. Liew, E. Thornton, B. Rogers, W. Tormey, and A. Agha, “Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis,” Clinical Endocrinology, vol. 69, no. 4, pp. 603–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. L. Jones, P. J. Trainer, L. Perry, J. A. H. Wass, G. M. Besser, and A. Grossman, “An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year,” Clinical Endocrinology, vol. 41, no. 1, pp. 123–128, 1994. View at Scopus
  25. G. Aimaretti, C. Baffoni, L. DiVito et al., “Comparisons among old and new provocative tests of GH secretion in 178 normal adults,” European Journal of Endocrinology, vol. 142, no. 4, pp. 347–352, 2000. View at Scopus
  26. K. S. Leong, A. B. Walker, I. Martin, D. Wile, J. Wilding, and I. A. MacFarlane, “An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease,” Clinical Endocrinology, vol. 54, no. 4, pp. 463–468, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Gómez, R. M. Espadero, F. Escobar-Jiménez et al., “Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults,” Clinical Endocrinology, vol. 56, no. 3, pp. 329–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. L. Conceição, A. da Costa e Silva, A. J. Leal Costa, and M. Vaisman, “Glucagon stimulation test for the diagnosis of GH deficiency in adults,” Journal of Endocrinological Investigation, vol. 26, no. 11, pp. 1065–1070, 2003. View at Scopus
  29. C. Berg, T. Meinel, H. Lahner, A. Yuece, K. Mann, and S. Petersenn, “Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery,” European Journal of Endocrinology, vol. 162, no. 3, pp. 477–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. J. Trainer and G. M. Besser, The Bart's Endocrine Protcols, Churchill Livingstone International, Edinburgh, UK, 1995.
  31. M. L. Mitchell, P. Suvunrungsi, and C. T. Sawin, “Effect of propranolol on the response of serum growth hormone to glucagon,” Journal of Clinical Endocrinology and Metabolism, vol. 32, no. 4, pp. 470–475, 1971. View at Scopus
  32. J. P. Cain, G. H. Williams, and R. G. Dluhy, “Glucagon-initiated human growth hormone release: a comparative study,” Canadian Medical Association Journal, vol. 107, no. 7, pp. 617–622, 1972. View at Scopus
  33. A. Rahim, A. A. Toogood, and S. M. Shalet, “The assessment of growth hormone status in normal young adult males using a variety of provocative agents,” Clinical Endocrinology, vol. 45, no. 5, pp. 557–562, 1996. View at Scopus
  34. S. M. Webb, C. J. Strasburger, D. Mo et al., “Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 392–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Ghigo, G. Aimaretti, L. Gianotti, J. Bellone, E. Arvat, and F. Camanni, “New approach to the diagnosis of growth hormone deficiency in adults,” European Journal of Endocrinology, vol. 134, no. 3, pp. 352–356, 1996. View at Scopus
  36. G. Aimaretti, G. Corneli, P. Razzore et al., “Comparison between insulin-induced hypoglycemia and growth hormone (GH)- releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 5, pp. 1615–1618, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. B. M. K. Biller, M. H. Samuels, A. Zagar et al., “Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2067–2079, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Chanson, A. Cailleux-Bounacer, J. M. Kuhn et al., “Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 8, pp. 3684–3692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. A. Bushinsky and F. J. Gennari, “Life-threatening hyperkalemia induced by arginine,” Annals of Internal Medicine, vol. 89, no. 5, pp. 632–634, 1978. View at Scopus
  40. K. H. Darzy, G. Aimaretti, G. Wieringa, H. Rao Gattamaneni, E. Ghigo, and S. M. Shalet, “The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 1, pp. 95–102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. J. N. Ham, J. P. Ginsberg, C. D. Hendell, and T. Moshang, “Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy,” Clinical Endocrinology, vol. 62, no. 5, pp. 628–632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Björk, K. Link, and E. M. Erfurth, “The utility of the growth hormone (GH) releasing hormone-arginine test for diagnosing gh deficiency in adults with childhood acute lymphoblastic leukemia treated with cranial irradiation,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6048–6054, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Popovic, S. Pekic, I. Golubicic, M. Doknic, C. Dieguez, and F. F. Casanueva, “The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2095–2099, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. H. C. Hoeck, P. Vestergaard, P. E. Jakobsen, J. Falhof, and P. Laurberg, “Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-Releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1467–1472, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Abs, “Update on the diagnosis of GH deficiency in adults,” European Journal of Endocrinology, vol. 148, 2, pp. S3–S8, 2003.
  46. V. Popovic, A. Leal, D. Micic et al., “GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults,” The Lancet, vol. 356, no. 9236, pp. 1137–1142, 2000. View at Scopus
  47. T. Mahajan and S. L. Lightman, “A simple test for growth hormone deficiency in adults,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1473–1476, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Aimaretti, C. Baffoni, F. Broglio et al., “Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency,” Clinical Endocrinology, vol. 56, no. 6, pp. 765–771, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Colao, C. Di Somma, S. Savastano et al., “A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4414–4422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. A. Toogood, P. A. O'Neill, and S. M. Shalet, “Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 2, pp. 460–465, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. A. A. Toogood, R. M. Nass, S. S. Pezzoli, P. A. O'Neill, M. O. Thorner, and S. M. Shalet, “Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 7, pp. 2215–2221, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Williams, M. Berelowitz, and S. N. Joffe, “Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction,” The New England Journal of Medicine, vol. 311, no. 22, pp. 1403–1407, 1984. View at Scopus
  53. M. H. Rasmussen, A. Hvidberg, A. Juul et al., “Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 4, pp. 1407–1415, 1995. View at Scopus
  54. V. S. Bonert, J. D. Elashoff, P. Barnett, and S. Melmed, “Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3397–3401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Maccario, C. Gauna, M. Procopio et al., “Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test,” Journal of Endocrinological Investigation, vol. 22, no. 6, pp. 424–429, 1999. View at Scopus
  56. A. Iranmanesh, G. Lizarralde, and J. D. Veldhuis, “Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men,” Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 5, pp. 1081–1088, 1991. View at Scopus
  57. S. Loche, C. Pintor, M. Cappa et al., “Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children,” Acta Endocrinologica, vol. 120, no. 5, pp. 624–628, 1989. View at Scopus
  58. A. E. Pontiroli, R. Lanzi, L. D. Monti, E. Sandoli, and G. Pozza, “Growth hormone (GH) autofeedback on GH response to GH-releasing hormone. Role of free fatty acids and somatostatin,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 2, pp. 492–495, 1991. View at Scopus
  59. G. Corneli, C. Di Somma, R. Baldelli et al., “The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index,” European Journal of Endocrinology, vol. 153, no. 2, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. A. C. S. Faria, L. W. Bekenstein, R. A. Booth et al., “Pulsatile growth hormone release in normal women during the menstrual cycle,” Clinical Endocrinology, vol. 36, no. 6, pp. 591–596, 1992. View at Scopus
  61. K. E. Friend, M. L. Hartman, S. S. Pezzoli, J. L. Clasey, and M. O. Thorner, “Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A clinical research center study,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 6, pp. 2250–2256, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. A. J. Weissberger, K. K. Y. Ho, and L. Lazarus, “Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 2, pp. 374–381, 1991. View at Scopus
  63. A. Pokrajac, G. Wark, A. R. Ellis, J. Wear, G. E. Wieringa, and P. J. Trainer, “Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice,” Clinical Endocrinology, vol. 67, no. 1, pp. 65–70, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. D. R. Clemmons, “Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays,” Clinical Chemistry, vol. 57, no. 4, pp. 555–559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Bidlingmaier and C. J. Strasburger, “Growth hormone assays: current methodologies and their limitations,” Pituitary, vol. 10, no. 2, pp. 115–119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. P. J. Trainer, J. Barth, C. Sturgeon, and G. Wieringa, “Consensus statement on the standardisation of GH assays,” European Journal of Endocrinology, vol. 155, no. 1, pp. 1–2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Frystyk, P. Freda, and D. R. Clemmons, “The current status of IGF-I assays—a 2009 update,” Growth Hormone and IGF Research, vol. 20, no. 1, pp. 8–18, 2010. View at Publisher · View at Google Scholar · View at Scopus